Which strategies reduce breast cancer mortality most?. Issue 14 (26th April 2013)
- Record Type:
- Journal Article
- Title:
- Which strategies reduce breast cancer mortality most?. Issue 14 (26th April 2013)
- Main Title:
- Which strategies reduce breast cancer mortality most?
- Authors:
- Mandelblatt, Jeanne
van Ravesteyn, Nicolien
Schechter, Clyde
Chang, Yaojen
Huang, An‐Tsun
Near, Aimee M.
de Koning, Harry
Jemal, Ahmedin - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cncr28087-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>US breast cancer mortality is declining, but thousands of women still die each year.</p> </sec> <sec id="cncr28087-sec-0002" sec-type="section"> <title>METHODS</title> <p>Two established simulation models examine 6 strategies that include increased screening and/or treatment or elimination of obesity versus continuation of current patterns. The models use common national data on incidence and obesity prevalence, competing causes of death, mammography characteristics, treatment effects, and survival/cure. Parameters are modified based on obesity (defined as BMI ≥ 30 kg/m<sup>2</sup>). Outcomes are presented for the year 2025 among women aged 25+ and include numbers of cases, deaths, mammograms and false‐positives; age‐adjusted incidence and mortality; breast cancer mortality reduction and deaths averted; and probability of dying of breast cancer.</p> </sec> <sec id="cncr28087-sec-0003" sec-type="section"> <title>RESULTS</title> <p>If current patterns continue, the models project that there would be about 50, 100‐57, 400 (range across models) annual breast cancer deaths in 2025. If 90% of women were screened annually from ages 40 to 54 and biennially from ages 55 to 99 (or death), then 5100‐6100 fewer deaths would occur versus current patterns, but incidence, mammograms, and false‐positives would increase. If all<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="cncr28087-sec-0001" sec-type="section"> <title>BACKGROUND</title> <p>US breast cancer mortality is declining, but thousands of women still die each year.</p> </sec> <sec id="cncr28087-sec-0002" sec-type="section"> <title>METHODS</title> <p>Two established simulation models examine 6 strategies that include increased screening and/or treatment or elimination of obesity versus continuation of current patterns. The models use common national data on incidence and obesity prevalence, competing causes of death, mammography characteristics, treatment effects, and survival/cure. Parameters are modified based on obesity (defined as BMI ≥ 30 kg/m<sup>2</sup>). Outcomes are presented for the year 2025 among women aged 25+ and include numbers of cases, deaths, mammograms and false‐positives; age‐adjusted incidence and mortality; breast cancer mortality reduction and deaths averted; and probability of dying of breast cancer.</p> </sec> <sec id="cncr28087-sec-0003" sec-type="section"> <title>RESULTS</title> <p>If current patterns continue, the models project that there would be about 50, 100‐57, 400 (range across models) annual breast cancer deaths in 2025. If 90% of women were screened annually from ages 40 to 54 and biennially from ages 55 to 99 (or death), then 5100‐6100 fewer deaths would occur versus current patterns, but incidence, mammograms, and false‐positives would increase. If all women received the indicated systemic treatment (with no screening change), then 11, 400‐14, 500 more deaths would be averted versus current patterns, but increased toxicity could occur. If 100% received screening plus indicated therapy, there would be 18, 100‐20, 400 fewer deaths. Eliminating obesity yields 3300‐5700 fewer breast cancer deaths versus continuation of current obesity levels.</p> </sec> <sec id="cncr28087-sec-0004" sec-type="section"> <title>CONCLUSIONS</title> <p>Maximal reductions in breast cancer deaths could be achieved through optimizing treatment use, followed by increasing screening use and obesity prevention. <bold><italic>Cancer</italic> 2013;119:2541–2548</bold>. © <italic>2013 American Cancer Society</italic>.</p> </sec> </abstract> … (more)
- Is Part Of:
- Cancer. Volume 119:Issue 14(2013)
- Journal:
- Cancer
- Issue:
- Volume 119:Issue 14(2013)
- Issue Display:
- Volume 119, Issue 14 (2013)
- Year:
- 2013
- Volume:
- 119
- Issue:
- 14
- Issue Sort Value:
- 2013-0119-0014-0000
- Page Start:
- 2541
- Page End:
- 2548
- Publication Date:
- 2013-04-26
- Subjects:
- Cancer -- Periodicals
Cancer -- Cytopathology -- Periodicals
616.99405 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0142 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cncr.28087 ↗
- Languages:
- English
- ISSNs:
- 0008-543X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3046.450000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3253.xml